Regulatory Perspectives on Nose-to-Brain Delivery Pathways to Accelerate Safe and Compliant CNS Drug Development
- Clarify regulatory expectations for intranasal drugs targeting the CNS
- Explore how FDA and EMA evaluate device/formulation combination products for safety and efficacy
- Provide guidance for designing preclinical and clinical packages to support regulatory approval